Panel Discussion Drug Registration And Listing 2018

Panel Discussion (4/7) Drug Registration and Listing 2018

U.S. Food and Drug Administration

Panel Questions and Discussion (4of8) Drug Registration and Listing Using CDER Direct - Oct 22, 2019

U.S. Food and Drug Administration

The State of Drug Registration and Listing (DRLS) (1/7) Drug Registration and Listing 2018

U.S. Food and Drug Administration

Panel Questions and Discussion (8of8) Registration and Listing - Oct. 22, 2019

U.S. Food and Drug Administration

503B Product Reporting for Compounding Outsourcing Facilities (7/7) Drug Registration & Listing 2018

U.S. Food and Drug Administration

Drug Product Listing & Listing Certification (5/7) Drug Registration and Listing 2018

U.S. Food and Drug Administration

Final Panel Discussion – All Topics (39of39) Complex Generics 2018

U.S. Food and Drug Administration

FDA Registration and Listing Compliance Program (6/7) Drug Registration and Listing 2018

U.S. Food and Drug Administration

Panel Discussion (31of39) Complex Generics 2018

U.S. Food and Drug Administration

Panel Discussion (27of27) Generic Drugs Forum April 11-12, 2018

U.S. Food and Drug Administration

Panel Discussion (9of27) Generic Drugs Forum 2018

U.S. Food and Drug Administration

NDC Reservation Request (3/7) Drug Registration and Listing 2018

U.S. Food and Drug Administration

Questions and Panel Discussion (16of39) Complex Generics 2018

U.S. Food and Drug Administration

Panel Discussion (20of27) Generic Drugs Forum 2018

U.S. Food and Drug Administration

Panel Discussion (13of27) Generic Drugs Forum 2018

U.S. Food and Drug Administration

Establishment Registration and Labeler Code Requests (2/7) Drug Registration and Listing 2018

U.S. Food and Drug Administration

Questions and Panel Discussion (20of39) Complex Generics 2018

U.S. Food and Drug Administration

Panel Discussion

U.S. Food and Drug Administration

Questions and Panel Discussion (9of39) Complex Generics 2018

U.S. Food and Drug Administration

Questions and Panel Discussion (5of39) Complex Generics 2018

U.S. Food and Drug Administration